Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Mabuchi

Showing results (21-30 of 288) with videos related to

Pageof 29
Sort By:
International Journal of Cardiology|March 18, 2005
Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis TrialMasami Shimizu, Junji Koizumi, Susumu Miyamoto, et al.
Circulation|February 13, 2002
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophyYoshiyu Takeda, Takashi Yoneda, Masashi Demura, et al.
Heartrhythm Case Reports|January 24, 2024
Contrast drainage through pre-existing transseptal route during left bundle branch area pacingMasahiro Kimura, Chisato Miura, Tomohiro Osaki, et al.
Journal of Gastroenterology and Hepatology|September 22, 2005
Two male patients with Wilson's disease treated using trientine and iron reduction therapyHisao Hayashi, Toshio Ueno, Motoyoshi Yano, et al.
Clinical Science (London, England : 1979)|November 26, 2002
Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemiaZhiping Huang, Akihiro Inazu, Atsushi Nohara, et al.
Journal of Atherosclerosis and Thrombosis|November 1, 2002
Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT)Junji Koizumi, Masami Shimizu, Susumu Miyamoto, et al.
Endocrine|February 16, 2005
Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese populationHua Liang, Kunimasa Yagi, Akimichi Asano, et al.
Journal of Cardiovascular Electrophysiology|May 10, 2005
A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugsHideki Itoh, Masami Shimizu, Shigeo Takata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2007
Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteriaJunji Kobayashi, Kouji Nishimura, Munetoshi Matoba, et al.
The Biochemical Journal|September 21, 2004
Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMPShin-ya Nagasawa, Noriko Takuwa, Naotoshi Sugimoto, et al.
Pageof 29

Showing results (21-30 of 288) with videos related to

Sort By:
Pageof 29
International Journal of Cardiology|March 18, 2005
Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis TrialMasami Shimizu, Junji Koizumi, Susumu Miyamoto, et al.
Circulation|February 13, 2002
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophyYoshiyu Takeda, Takashi Yoneda, Masashi Demura, et al.
Heartrhythm Case Reports|January 24, 2024
Contrast drainage through pre-existing transseptal route during left bundle branch area pacingMasahiro Kimura, Chisato Miura, Tomohiro Osaki, et al.
Journal of Gastroenterology and Hepatology|September 22, 2005
Two male patients with Wilson's disease treated using trientine and iron reduction therapyHisao Hayashi, Toshio Ueno, Motoyoshi Yano, et al.
Clinical Science (London, England : 1979)|November 26, 2002
Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemiaZhiping Huang, Akihiro Inazu, Atsushi Nohara, et al.
Journal of Atherosclerosis and Thrombosis|November 1, 2002
Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT)Junji Koizumi, Masami Shimizu, Susumu Miyamoto, et al.
Endocrine|February 16, 2005
Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese populationHua Liang, Kunimasa Yagi, Akimichi Asano, et al.
Journal of Cardiovascular Electrophysiology|May 10, 2005
A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugsHideki Itoh, Masami Shimizu, Shigeo Takata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 30, 2007
Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteriaJunji Kobayashi, Kouji Nishimura, Munetoshi Matoba, et al.
The Biochemical Journal|September 21, 2004
Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMPShin-ya Nagasawa, Noriko Takuwa, Naotoshi Sugimoto, et al.
Pageof 29